29Jan 2023
Cognitive impairment does not impact sacral neuromodulation implant rates for overactive bladder

Cognitive impairment does not impact sacral neuromodulation implant rates for overactive bladder

A retrospective study evaluated the impact of cognitive impairment (CI) diagnoses on sacral neuromodulation (SNM) outcomes in older patients. Overall, 52 patients had a CI diagnosis at the time of SNM, and 30 were diagnosed at a median of 18.5 months after SNM. Patients with CI diagnoses were older, with more comorbidities, and were more likely to undergo PNE. The univariable comparison found no difference in implantation rate based on pre‐SNM CI. Explant and revision rates did not differ according to CI. The results show that patients with OAB and CI diagnoses proceed to SNM implants at rates similar to those without CI diagnoses. Therefore, a diagnosis of CI should not necessarily exclude patients from SNM therapy for refractory OAB.

  • #urology

Like

Save

Share